General Information of Drug Off-Target (DOT) (ID: OTMBE0NS)

DOT Name MOB kinase activator 2 (MOB2)
Synonyms HCCA2; Mob2 homolog; Mps one binder kinase activator-like 2
Gene Name MOB2
Related Disease
Carcinoma of liver and intrahepatic biliary tract ( )
Familial prostate carcinoma ( )
Hepatocellular carcinoma ( )
Liver cancer ( )
Neoplasm ( )
Periventricular nodular heterotopia ( )
Prostate cancer, hereditary, 1 ( )
Prostate carcinoma ( )
Non-insulin dependent diabetes ( )
UniProt ID
MOB2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF03637
Sequence
MDWLMGKSKAKPNGKKPAAEERKAYLEPEHTKARITDFQFKELVVLPREIDLNEWLASNT
TTFFHHINLQYSTISEFCTGETCQTMAVCNTQYYWYDERGKKVKCTAPQYVDFVMSSVQK
LVTDEDVFPTKYGREFPSSFESLVRKICRHLFHVLAHIYWAHFKETLALELHGHLNTLYV
HFILFAREFNLLDPKETAIMDDLTEVLCSGAGGVHSGGSGDGAGSGGPGAQNHVKER
Function Stimulates the autophosphorylation and kinase activity of STK38 and STK38L.

Molecular Interaction Atlas (MIA) of This DOT

9 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Carcinoma of liver and intrahepatic biliary tract DIS8WA0W Strong Biomarker [1]
Familial prostate carcinoma DISL9KNO Strong Biomarker [2]
Hepatocellular carcinoma DIS0J828 Strong Altered Expression [1]
Liver cancer DISDE4BI Strong Biomarker [1]
Neoplasm DISZKGEW Strong Biomarker [1]
Periventricular nodular heterotopia DISU3ZRI Strong Genetic Variation [3]
Prostate cancer, hereditary, 1 DISE2P4L Strong Biomarker [2]
Prostate carcinoma DISMJPLE Strong Genetic Variation [2]
Non-insulin dependent diabetes DISK1O5Z Limited Genetic Variation [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
5 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of MOB kinase activator 2 (MOB2). [5]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of MOB kinase activator 2 (MOB2). [6]
Aspirin DM672AH Approved Aspirin increases the expression of MOB kinase activator 2 (MOB2). [9]
Urethane DM7NSI0 Phase 4 Urethane increases the expression of MOB kinase activator 2 (MOB2). [10]
Leflunomide DMR8ONJ Phase 1 Trial Leflunomide decreases the expression of MOB kinase activator 2 (MOB2). [12]
------------------------------------------------------------------------------------
4 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Arsenic DMTL2Y1 Approved Arsenic affects the methylation of MOB kinase activator 2 (MOB2). [7]
Fulvestrant DM0YZC6 Approved Fulvestrant affects the methylation of MOB kinase activator 2 (MOB2). [8]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of MOB kinase activator 2 (MOB2). [11]
Bisphenol A DM2ZLD7 Investigative Bisphenol A affects the methylation of MOB kinase activator 2 (MOB2). [8]
------------------------------------------------------------------------------------

References

1 Identification and characterization of a novel human hepatocellular carcinoma-associated gene.Br J Cancer. 2001 Oct 19;85(8):1162-7. doi: 10.1054/bjoc.2001.2059.
2 Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.Nat Genet. 2018 Jul;50(7):928-936. doi: 10.1038/s41588-018-0142-8. Epub 2018 Jun 11.
3 Mob2 Insufficiency Disrupts Neuronal Migration in the Developing Cortex.Front Cell Neurosci. 2018 Mar 12;12:57. doi: 10.3389/fncel.2018.00057. eCollection 2018.
4 Strong parent-of-origin effects in the association of KCNQ1 variants with type 2 diabetes in American Indians.Diabetes. 2013 Aug;62(8):2984-91. doi: 10.2337/db12-1767. Epub 2013 Apr 29.
5 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
6 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
7 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
8 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
9 Effects of aspirin on metastasis-associated gene expression detected by cDNA microarray. Acta Pharmacol Sin. 2004 Oct;25(10):1327-33.
10 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
11 Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem Toxicol. 2018 Nov;121:214-223. doi: 10.1016/j.fct.2018.08.034. Epub 2018 Aug 26.
12 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.